BCG stimulation promotes dendritic cell proliferation and expression of VDR and CYP27B1 in vitamin D‑deficient mice

Yang,Huifeng; Zhang,Haocong; Li,Yu; Xiang,Liangbi; Liu,Jun

doi:10.3892/mmr.2019.10780

BCG stimulation promotes dendritic cell proliferation and expression of VDR and CYP27B1 in vitamin D‑deficient mice

Authors:
- Huifeng Yang
- Haocong Zhang
- Yu Li
- Liangbi Xiang
- Jun Liu
View Affiliations

Affiliations: Department of Orthopedics, General Hospital of Northern Theater Command, Shenyang, Liaoning 110015, P.R. China
Published online on: October 30, 2019 https://doi.org/10.3892/mmr.2019.10780
Pages: 5265-5271

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Vitamin D deficiency may lead to an increased risk of tuberculosis. In the present study, the effects of Mycobacterium tuberculosis (Mtb) infection on dendritic cells (DCs) derived from vitamin D‑deficient mice or normal control mice were investigated. A vitamin D‑deficient mouse model was established, and bone marrow‑derived DCs (BMDCs) were isolated and treated with GM‑CSF and interleukin (IL)‑4 for 6 days, followed by an additional 24 h of treatment with Bacillus Calmette‑Guérin (BCG). The expression levels of surface molecules of DCs, including integrin alpha‑X and T‑lymphocyte activation antigen CD86, were significantly increased by BCG in the vitamin D‑deficient mice model group compared with the control group, while those of T‑lymphocyte activation antigen CD80, major histocompatibility complex class I and major histocompatibility complex class II were significantly decreased. These changes were BCG concentration‑dependent. In addition, the levels of IL‑4, IL‑6 and IL‑10 in the BMDCs from the vitamin D‑deficient mice were significantly decreased compared with the control mice, while the levels of tumor necrosis factor‑α, IL‑5, IL‑2, IL‑12 and interferon‑γ were significantly increased. Furthermore, the expression levels of vitamin D receptor (VDR) and CYP27B1 protein in the BMDCs from the vitamin D‑deficient mice were decreased compared with the control. BCG significantly increased the expression levels of VDR and CYP27B1 in the BMDCs. The DCs treated with BCG significantly induced the viability of CD4+ T lymphocytes. Therefore, BCG increases DCs and may enhance immunofunction, which may assist in preventing the risk of tuberculosis in patients with a vitamin D deficiency.

View Figures

View References

1	Flynn JL: Immunology of tuberculosis and implications in vaccine development. Tuberculosis (Edinb). 84:93–101. 2004. View Article : Google Scholar : PubMed/NCBI
2	Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K, Meinken C, et al: Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 311:1770–1773. 2006. View Article : Google Scholar : PubMed/NCBI
3	Talat N, Perry S, Parsonnet J, Dawood G and Hussain R: Vitamin D deficiency and tuberculosis progression. Emerg Infect Dis. 16:853–855. 2010. View Article : Google Scholar : PubMed/NCBI
4	Zignol M, van Gemert W, Falzon D, Sismanidis C, Glaziou P, Floyd K and Raviglione M: Surveillance of anti-tuberculosis drug resistance in the world: An updated analysis, 2007–2010. Bull World Health Organ. 90:111–119D. 2012. View Article : Google Scholar : PubMed/NCBI
5	Goswami R, Mishra SK and Kochupillai N: Prevalence & potential significance of vitamin D deficiency in Asian Indians. Indian J Med Res. 127:229–238. 2008.PubMed/NCBI
6	Holick MF: Vitamin D deficiency. N Engl J Med. 357:266–281. 2007. View Article : Google Scholar : PubMed/NCBI
7	Querfeld U: Vitamin D and inflammation. Pediatr Nephrol. 28:605–610. 2013. View Article : Google Scholar : PubMed/NCBI
8	Dusso AS, Brown AJ and Slatopolsky E: Vitamin D. Am J Physiol Renal Physiol. 289:F8–F28. 2005. View Article : Google Scholar : PubMed/NCBI
9	Pike JW and Meyer MB: The vitamin D receptor: New paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D3. Rheum Dis Clin North Am. 38:13–27. 2012. View Article : Google Scholar : PubMed/NCBI
10	Chen Y, Liu W, Sun T, Huang Y, Wang Y, Deb DK, Yoon D, Kong J, Thadhani R and Li YC: 1,25-Dihydroxyvitamin D promotes negative feedback regulation of TLR signaling via targeting microRNA-155-SOCS1 in macrophages. J Immunol. 190:3687–3695. 2013. View Article : Google Scholar : PubMed/NCBI
11	Von Essen MR, Kongsbak M, Schjerling P, Olgaard K, Ødum N and Geisler C: Vitamin D controls T cell antigen receptor signaling and activation of human T cells. Nat Immunol. 11:344–349. 2010. View Article : Google Scholar : PubMed/NCBI
12	Rook GA, Steele J, Fraher L, Barker S, Karmali R, O'Riordan J and Stanford J: Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology. 57:159–163. 1986.PubMed/NCBI
13	Bikle DD: Vitamin D and the immune system: Role in protection against bacterial infection. Curr Opin Nephrol Hypertens. 17:348–352. 2008. View Article : Google Scholar : PubMed/NCBI
14	Veldman CM, Cantorna MT and DeLuca HF: Expression of 1,25-dihydroxyvitamin D (3) receptor in the immune system. Arch Biochem Biophys. 374:334–338. 2000. View Article : Google Scholar : PubMed/NCBI
15	Miziara ID, Magalhaes AT, Santos M, Gomes EF and Oliveira RA: Research ethics in animal models. Braz J Otorhinolaryngol (Article in English, Portuguese). 78:128–131. 2012. View Article : Google Scholar
16	Wu SY, Chen WH, Hsieh CL and Lin YW: Abundant expression and functional participation of TRPV1 at Zusanli acupoint (ST36) in mice: Mechanosensitive TRPV1 as an ‘acupuncture-responding channel’. BMC Complement Altern Med. 14:962014. View Article : Google Scholar : PubMed/NCBI
17	Liang Z, Xie Y, Dominguez JA, Breed ER, Yoseph BP, Burd EM, Farris AB, Davidson NO and Coopersmith CM: Intestine-specific deletion of microsomal triglyceride transfer protein increases mortality in aged mice. PLoS One. 9:e1018282014. View Article : Google Scholar : PubMed/NCBI
18	https://www.nc3rs.org.uk/arrive-guidelines
19	Zeng Y and Liu J: Role of glypican-1 in endothelial NOS activation under various steady shear stress magnitudes. Exp Cell Res. 348:184–189. 2016. View Article : Google Scholar : PubMed/NCBI
20	Zeng Y, Yao X, Liu X, He X, Li L, Liu X, Yan Z, Wu J and Fu BM: Anti-angiogenesis triggers exosomes release from endothelial cells to promote tumor vasculogenesis. J Extracellular Vesicles. 8:16298652019. View Article : Google Scholar
21	Gibney KB, MacGregor L, Leder K, Torresi J, Marshall C, Ebeling PR and Biggs BA: Vitamin D deficiency is associated with tuberculosis and latent tuberculosis infection in immigrants from Sub-Saharan Africa. Clin Infect Dis. 46:443–446. 2008. View Article : Google Scholar : PubMed/NCBI
22	Huang SJ, Wang XH, Liu ZD, Cao WL, Han Y, Ma AG and Xu SF: Vitamin D deficiency and the risk of tuberculosis: A meta-analysis. Drug Des Devel Ther. 11:91–102. 2016. View Article : Google Scholar : PubMed/NCBI
23	Penna G and Adorini L: 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol. 164:2405–2411. 2000. View Article : Google Scholar : PubMed/NCBI
24	Mosmann TR, Cherwinski H, Bond MW, Giedlin MA and Coffman RL: Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 136:2348–2357. 1986.PubMed/NCBI
25	Lichtner M, Rossi R, Mengoni F, Vignoli S, Colacchia B, Massetti AP, Kamga I, Hosmalin A, Vullo V and Mastroianni CM: Circulating dendritic cells and interferon-alpha production in patients with tuberculosis: Correlation with clinical outcome and treatment response. Clin Exp Immunol. 143:329–337. 2006. View Article : Google Scholar : PubMed/NCBI
26	Dominguez J, De Souza-Galvao M, Ruiz-Manzano J, Latorre I, Prat C, Lacoma A, Milà C, Jiménez MA, Blanco S, Maldonado J, et al: T-cell responses to the mycobacterium tuberculosis-specific antigens in active tuberculosis patients at the beginning, during, and after antituberculosis treatment. Diagn Microbiol Infect Dis. 63:43–51. 2009. View Article : Google Scholar : PubMed/NCBI
27	Infante-Duarte C and Kamradt T: Th1/Th2 balance in infection. Springer Semin Immunopathol. 21:317–338. 1999. View Article : Google Scholar : PubMed/NCBI
28	He XY, Xiao L, Chen HB, Hao J, Li J, Wang YJ, He K, Gao Y and Shi BY: T regulatory cells and Th1/Th2 cytokines in peripheral blood from tuberculosis patients. Eur J Clin Microbiol Infect Dis. 29:643–650. 2010. View Article : Google Scholar : PubMed/NCBI
29	Nemeth J, Winkler HM, Boeck L, Adegnika AA, Clement E, Mve TM, Kremsner PG and Winkler S: Specific cytokine patterns of pulmonary tuberculosis in Central Africa. Clin Immunol. 138:50–59. 2011. View Article : Google Scholar : PubMed/NCBI
30	Handzel ZT, Barak V, Altman Y, Bibi H, Lidgi M, Iancovici-Kidon M, Yassky D and Raz M: Increased Th1 and Th2 type cytokine production in patients with active tuberculosis. Isr Med Assoc J. 9:479–483. 2007.PubMed/NCBI
31	Flynn JL, Goldstein MM, Triebold KJ, Sypek J, Wolf S and Bloom BR: IL-12 increases resistance of BALB/c mice to mycobacterium tuberculosis infection. J Immunol. 155:2515–2524. 1995.PubMed/NCBI
32	Tissandié E, Guéguen Y, Lobaccaro JM, Aigueperse J and Souidi M: Vitamin D: Metabolism, regulation and associated diseases. Med Sci (Paris). 22:1095–1100. 2006.(In French). View Article : Google Scholar : PubMed/NCBI
33	Nebbioso M, Buomprisco G, Pascarella A and Pescosolido N: Modulatory effects of 1,25-dihydroxyvitamin D3 on eye disorders: A critical review. Crit Rev Food Sci Nutr. 57:559–565. 2017. View Article : Google Scholar : PubMed/NCBI
34	Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF and O'Garra A: 1α,25-Dihydroxyvitamin D3 has a direct effect on naive CD4⁺ T Cells to enhance the development of Th2 cells. J Immunol. 167:4974–4980. 2001. View Article : Google Scholar : PubMed/NCBI
35	Gregori S, Casorati M, Amuchastegui S, Smiroldo S, Davalli AM and Adorini L: Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol. 167:1945–1953. 2001. View Article : Google Scholar : PubMed/NCBI